Press & Events

RENDER: Exciting presence at MEDICA to demonstrate global excellenceRelease time:2023-11-15    14:14:00

The 55th edition of MEDICA, the medical exhibition in Düsseldorf, was held on November 13, 2023 at the Düsseldorf Exhibition Center in Germany. As the leading trade fair for the medical industry, MEDICA attracts professionals from all over the world every year to visit and discuss the latest developments and innovations in the medical field.

RENDER set sail with its highlight items and appeared at Booth No. H3-K72, showing a wide range of cutting-edge medical technology, products, and solutions, exchanging and discussing with global customers and partners, and participating in this industry event.

The booth site demonstrated All Series Thrombelastography, POCT Chemiluminescence Immunoassay Analyzers, Microbiological Solutions, and other products, as well as a variety of rich product lines. The attendees stayed there, attracting many customers to stop to watch and communicate,these include the newly launched IHTEG6 High Throughput Automated Thrombelastography and IMASP 4 Automatic Microbial Specimen Preprocessing system, which won great attention from professionals. they spoke highly of RENDER's products and were excited about the company's technology and new products.

Thrombosis and coagulation tests are RENDER's star products in in vitro diagnostics, including IHTEG6 High Throughput Automated Thrombelastography, which is the first to lead thromboelastography into the era of high-throughput automation, the classic routine coagulation test reagents, and new thrombus test markers based on chemiluminescent platforms, which can help doctors understand coagulation more comprehensively and is an indispensable tool in the clinical laboratory.

In the field of microbiology, RENDER offers the advanced IMASP 4 Automatic Microbial Specimen Preprocessing System, which makes microbial sample pre-processing more efficient, standardized, accurate, and safer for personnel.

RENDER will continue to uphold the original intention to become the world's top in vitro diagnostic automation enterprise as its own responsibility, continuously improve product quality, promote product application development, actively embrace the global market, assist customers to complete the design and manufacture of high-performance products, realize the company's "focus on value creation, quality, and innovation to serve the life of" the company's mission, and work with customers to create a better future. To realize the company's mission of "focusing on value creation, serving life with quality and innovation", and to create a better future hand in hand with our customers.